Risk minimization measures
Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| Quetiapine | Adazio | View | ||
| Pegfilgrastim | Ziextenzo | View | ||
| Isotretinoin | Ruatine | View | ||
| Levofloxacin | Eradocin | View | ||
| Warfarin | Warfarin | View | ||
| Tisagenlecleucel | Kymriah | View | ||
| Adalimumab | Hyrimoz | View | ||
| Ipilimumab | Yervoy | View | ||
| Amoxicillin, Clavulanic Acid | Megamox | View | ||
| Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) | Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) | View |